{"id":184466,"name":"BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.)","slug":"biotechnology-innovation-organization-formerly-biotechnology-industry-org","state":"DC","country":"United States of America","description":"Represent organizations that promote research and support growth of biotechnology industry","totalSpending":2200000,"filings":33,"yearlySpending":[{"year":2018,"income":240000},{"year":2019,"income":290000},{"year":2020,"income":280000},{"year":2021,"income":360000},{"year":2022,"income":250000},{"year":2023,"income":200000},{"year":2024,"income":290000},{"year":2025,"income":290000}],"issues":["MMM","HCR","TAX","TRD","BUD"],"firms":["CAPITOL COUNSEL LLC"],"lobbyists":["CHARLES FRENCH","SHANNON FINLEY","DREW GOESL","DENISE HENRY MORRISEY","AARON COHEN","LUKE HATZIS","ANN JABLON","DAVID OLANDER","CAITLIN CANTER","JOSEPH EANNELLO","JEFFREY CARROLL","MICHELLE MATHY","JOHN MARTIN","ADAM CARASSO","CHARLES MICHAELS","KAREN STONE"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Treasury, Dept of","Health & Human Services, Dept of (HHS)","Executive Office of the President (EOP)","Food & Drug Administration (FDA)"],"sampleDescriptions":["Medicare Part B Coverage and Reimbursement issues, including issues related to the Medicare Part D Coverage.","Patient access to biotechnology treatments.","Legislative issues related to the implementation of tax reform.","Patient access to biotechnology treatments.","Medicare Parts B and coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage."],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}